inflammatix.com Open in urlscan Pro
160.153.0.163  Public Scan

Form analysis
0 forms found in the DOM

Text Content

 * Pipeline
   * TriVerity
   * Endotypes
   * Pipeline
 * Education
   * Acute Infection & Sepsis
   * Immune Response
   * Machine Learning
   * Advocacy
 * Evidence
   * Publications
   * Abstracts
 * News
   * News
   * Press Releases
   * ML Blogs
   * Podcasts
   * Media Contact
 * Careers
 * About
   * Leadership
   * Investors
   * Partner With Us
   * Awards
   * Certificates
 * Reach Out

Select Page
 * Pipeline
   * TriVerity
   * Endotypes
   * Pipeline
 * Education
   * Acute Infection & Sepsis
   * Immune Response
   * Machine Learning
   * Advocacy
 * Evidence
   * Publications
   * Abstracts
 * News
   * News
   * Press Releases
   * ML Blogs
   * Podcasts
   * Media Contact
 * Careers
 * About
   * Leadership
   * Investors
   * Partner With Us
   * Awards
   * Certificates
 * Reach Out

Our products are in development, are not for sale, and do not have marketing
approval or clearance from regulatory authorities in any jurisdiction.


TESTING DESIGNED TO FIT HOW EMERGENCY MEDICINE PHYSICIANS EVALUATE HARD TO
DIAGNOSE PATIENTS

Our products are in development, are not for sale, and do not have marketing
approval or clearance from regulatory authorities in any jurisdiction.

Interpreting the immune response, the TriVerity test informs on key clinically
actionable questions:

 * Does the patient have a bacterial or viral infection or a noninfectious
   condition?
 * Is the patient likely to need ICU-level intervention?

LEARN MORE ABOUT TRIVERITY


THE POWER OF THE IMMUNE RESPONSE TO DIAGNOSE ACUTE INFECTIONS AND SEPSIS




EMERGENCY DEPARTMENTS ACROSS THE US ROUTINELY SEE PATIENTS SUSPECTED OF ACUTE
INFECTION AND SEPSIS

In up to half of these patients, physicians struggle to make proper diagnosis
and prognosis and would welcome novel tools to assist them.1

20 million patients visit the emergency department each year suspected of an
acute infection2

1.7 million patients diagnosed with sepsis3

IMMUNE RESPONSE


EXPERTISE IN INTERPRETING THE IMMUNE RESPONSE

Inflammatix host response diagnostics are powered by ‘reading’ the immune
system. Our immune system has developed targeted responses to different types of
infections and other diseases over millions of years of evolution.



Leveraging our expertise in bioinformatics, including machine learning and
artificial intelligence, and molecular biology, we are harnessing the ability to
interpret the immune response to develop tests aimed to help physicians make
confident and timely clinical decisions.

Learn more about Host Response Dx
Most infections are locally contained and do not penetrate into the bloodstream.
This makes pathogen-targeting tests insensitive for infections. Immune cells
fight the infection locally and then circulate into the blood, where we can
measure their ‘signatures’ using mRNA profiles.


INFLAMMATIX IN THE NEWS

NEWSROOM


SOCIAL UPDATES

 * Follow
 * Follow


WANT MORE INFO?

Reach Out

 1. Data on file at Inflammatix.
 2. HCUPnet, Healthcare Cost and Utilization Project. Agency for Healthcare
    Research and Quality, Rockville, MD. 
 3. https://www.cdc.gov/sepsis/what-is-sepsis.html#anchor_1547214418, Last
    reviewed: August 24, 2023.

© Copyright2024, Inflammatix, Inc.     All Rights Reserved   |   Terms &
Conditions   |   Privacy & Cookies Statement
Inflammatix, TriVerity, Myrna, RespVerity, and BacVerity are trademarks of
Inflammatix, Inc.

 * Follow
 * Follow




Notifications